Material Transfer Agreements Clause Samples

Material Transfer Agreements. Sponsor acknowledges that where Labcorp enters into a material transfer agreement (“ MTA ”) with the provider of any HBS, Labcorp shall act in accordance with the terms of such MTA with respect to the disposition of any relevant HBS . In the event of a conflict between the terms of an MTA, this Agreement and any instructions provided by Sponsor, the terms of the MTA shall prevail . 5.

Material Transfer Agreements. Materials, for example biological materials, are often distributed by scientists to their colleagues for a variety of purposes, such as duplication and confirmation of experimental results or evaluation of the material for alternate uses. Such intellectual

Material Transfer Agreements. Materials, for example biological materials, are often distributed by scientists to their colleagues for a variety of purposes, such as duplication and confirmation of experimental results or evaluation of the material for alternate uses. Such intellectual property is an important factor in attracting research funding. For this reason, the university will help academic personnel review Material Transfer Agreements [MTAs] and other agreements that arise out of their interaction with industry. All such agreements must be approved by the Associate ▇▇▇▇▇▇▇, Research. In all cases, the university requires researchers to sign an MTA to ensure that these materials are used only for scientific research and not for commercial applications. If the material is being transferred for commercial application, its use shall be governed by a license agreement.

Material Transfer Agreements. Neither Medtronic nor any of its Affiliates is or has been a party to any Material Transfer Agreement.

Material Transfer Agreements. Material Transfer Agreements (MTAs) govern the transfer of one or more materials from the owner (or authorised licensee) (‘the provider’) to a third party (‘the recipient’) who may wish to use the material for research purposes. Materials can include cultures, cell lines, plasmids, nucleotides, proteins, bacteria, transgenic animals, pharmaceuticals, other chemicals, alloys and other materials with scientific or commercial value.

Material Transfer Agreements. Material Transfer Agreements govern the transfer of tangible research materials between the University and another company or institution. The Material Transfer Agreement defines the rights of the provider and the recipient with respect to the materials and any derivatives. It typically covers liability, confidentiality, and other relevant terms. Biological substances are the most frequently transferred materials, but Material Transfer Agreements may also be used for other types of materials, such as chemical compounds and even some types of software. The parties to the agreement must consider the facts of each situation in the negotiations of appropriate terms. Where to Start: For assistance with Material Transfer Agreements where the University will be the recipient of incoming materials, contact the Office of Sponsored Programs and Research Administration (OSPRA). If the University is purchasing the materials, consult the Purchasing Division. For assistance with Material Transfer Agreements where the University will be the provider of materials, contact the Office of Technology Management (OTM). a document and not its name determines whether it is an enforceable contract. Typically an MOU or MOA should be used when the parties want to document their intention to enter into a binding contract. In other words, the MOU will serve as the basis of a future formal contract. Sometimes the University will use an MOU or MOA to document arrangements between departments or units within the University. Keep in mind, however, that many parties, including foreign institutions, will issue a document titled “MOA” or “MOU” that contains legally binding obligations. An MOU or MOA must be routed, reviewed, approved and signed according to the same policies and procedures governing contracts. In addition, all MOU’s and ▇▇▇’s must be approved by the Chancellor’s Office. Where to Start: For assistance in determining whether an MOU/MOA is appropriate, contact the AVP Office or University Counsel.

Material Transfer Agreements. BZL and its Affiliates hereby assign and transfer to Millennium all of their respective rights, titles and interests in and to those material transfer agreements set forth on Schedule 3.3(d) hereto (the "MTAs"), which schedule is a true and complete list of all MTAs entered into by BZL or BZL Biologics, Inc. Millennium hereby agrees that it shall assume, insofar as they relate to the time period beginning on and including the day following the date hereof, all the obligations and liabilities of BZL under the MTAs. Millennium shall indemnify and hold harmless BZL and its Affiliates from any Losses with respect to any breach of any such MTA by Millennium or its Affiliates pursuant to Article IX.

Material Transfer Agreements. The parties acknowledge that, pursuant to a separate letter agreement, Amgen will assign to Immunomedics effective as of the Termination Effective Date certain of its rights, and Immunomedics will assume all of Amgen's obligations relating to such assigned rights, under the material transfer agreements listed on Exhibit F hereto (the "Material Transfer Agreements"), subject, in the case of each Material Transfer Agreement, to any required consent to such assignment of such Material Transfer Agreement. In particular, Amgen will assign its rights relating to data and results resulting from the conduct of the research program, intellectual property, publications and enforcement of such rights. [*] Amgen and Immunomedics shall cooperate in good faith to obtain any necessary consent to such assignment (and upon any such necessary consent being obtained, such assignment shall be deemed to have been effected hereby), provided that neither Immunomedics nor Amgen shall be required to pay any consideration to obtain such consent. To the extent any other obligations under the Material Transfer Agreements remain with Amgen, Immunomedics hereby grants to Amgen rights under the Licensed Patents Rights and Licensed Know How to the extent necessary for Amgen to satisfy its obligations under such Material Transfer Agreements.

Material Transfer Agreements. Purpose: An agreement between a Federal laboratory and a non-Federal party (e.g. ODU) to perform collaborative research and development to solve technical and industrial problems, often of broader societal impact.